Clinical trial
CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer - Phase 1
NCT04455282 is registered in ClinicalTrials.gov with Heinrich-Heine University, Duesseldorf as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer - Phase 1
- Lead sponsor
- Heinrich-Heine University, Duesseldorf
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 1, 2021
- Completion date
- January 30, 2028
- Enrollment
- 100 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cancer of esophagus, esophagogastric junction disorder